Prosecution Insights
Last updated: July 17, 2026
Application No. 18/541,175

MEDICAL SYSTEMS, DEVICES, AND RELATED METHODS

Non-Final OA §102§103
Filed
Dec 15, 2023
Priority
Dec 16, 2022 — provisional 63/387,758
Examiner
MCGRATH, ERIN E
Art Unit
4100
Tech Center
4100
Assignee
Boston Scientific Corporation
OA Round
1 (Non-Final)
60%
Grant Probability
Moderate
1-2
OA Rounds
11m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 60% of resolved cases
60%
Career Allowance Rate
262 granted / 437 resolved
At TC average
Strong +30% interview lift
Without
With
+29.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
25 currently pending
Career history
477
Total Applications
across all art units

Statute-Specific Performance

§101
0.1%
-39.9% vs TC avg
§103
92.8%
+52.8% vs TC avg
§102
1.8%
-38.2% vs TC avg
§112
5.1%
-34.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 437 resolved cases

Office Action

§102 §103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Specification The title of the invention is not descriptive. A new title is required that is clearly indicative of the invention to which the claims are directed. Claim Objections Claim 3 is objected to because of the following informalities: Claim 3 recites “coupled to track.” This should be “coupled to the track.” Appropriate correction is required. Claim Interpretation The claim 1 and 16 limitation “configured to be coupled to…another medical device” is considered met by a device capable of being coupled to another medical device, but the medical device is not a positively recited part of these claims so is not explicitly required. The following is a quotation of 35 U.S.C. 112(f): (f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked. As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph: (A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function; (B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and (C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function. Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function. Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function. Claim limitations in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. This application includes one or more claim limitations that do not use the word “means,” but are nonetheless being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, because the claim limitation(s) uses a generic placeholder that is coupled with functional language without reciting sufficient structure to perform the recited function and the generic placeholder is not preceded by a structural modifier. Such claim limitation(s) is/are: “control elements coupling the primary actuator to the movable portion of the end cap” in claims 1, 16, and 19, interpreted as “a coil, a tube, a sheath, a rod,” [Par. 0036] and “actuation element” in claim 1, interpreted as “a wire, a coil, a tube, a rod” [Par. 0036]. Because this/these claim limitation(s) is/are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, it/they is/are being interpreted to cover the corresponding structure described in the specification as performing the claimed function, and equivalents thereof. If applicant does not intend to have this/these limitation(s) interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, applicant may: (1) amend the claim limitation(s) to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph (e.g., by reciting sufficient structure to perform the claimed function); or (2) present a sufficient showing that the claim limitation(s) recite(s) sufficient structure to perform the claimed function so as to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-4, 15 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Whelehan et al. [US 2022/0265968 A1, hereinafter “Whelehan”]. Re. claim 1, Whelehan discloses a medical device [Fig. 2A], comprising: a handle [113, see Fig. 1A, 123, and 110, together], wherein the handle includes a primary actuator [123] and a secondary actuator [305]; an end cap [117 and 115, together] configured to be coupled to a distal end of another medical device [the cap is capable of such use; see Claim Interpretation, above], wherein the end cap includes a stationary portion [115] and a movable portion [117]; a patch [160], wherein the patch is coupled to the movable portion of the end cap [via 210, Fig. 2A]; one or more control elements [tube 120] coupling the primary actuator to the movable portion of the end cap; and an actuation element [wire 210], wherein the actuation element extends distally from the secondary actuator and the actuation element is configured to be coupled to the patch [Fig. 2A], wherein movement of the primary actuator moves the movable portion of the end cap relative to the stationary portion of the end cap [Fig. 2A, described for the first embodiment in Par. 0021-22], and wherein movement of the secondary actuator at least partially deploys the patch from the movable portion of the end cap [Par. 0031]. Re. claim 2, Whelehan discloses: The medical device of claim 1, wherein the handle includes a handle body [110 and 113, together], and wherein both the primary actuator and the secondary actuator are movable relative to the handle body [123 is movable relative to 110/113, see Fig. 2A, Par. 0021-22, and 305 is a knob or switch and movable (by turning or switching) relative to 110/113] to control the movement of the one or more control elements and the actuation element [Pars. 0021-22, 0031]. Re. claim 3, Whelehan discloses: The medical device of claim 2, wherein the handle body includes a track [110] and the primary actuator is movably coupled to track [Par. 0022], and wherein the primary actuator is configured to translate along the track in a first direction [backwards in Fig. 2A] and an opposite second direction [forwards in Fig. 2A]. Re. claim 4, Whelehan discloses: a translation of the primary actuator in the first direction is configured to translate the movable portion of the end cap distally relative to the stationary portion [Fig. 2A, Par. 0022], and wherein a translation of the primary actuator in the second direction is configured to translate the movable portion of the end cap proximally relative to the stationary portion [just as a backward motion moves the end cap distally, moving handle 123 in a forward direction would bring elements 117 and 115 closer together]. Re. claim 15, Whelehan discloses a sheath [124] configured to at least partially cover the patch and the end cap [see Figs. 1A-B], and wherein the sheath is retractable and/or the movable portion is extendable to expose the patch and at least the movable portion of the end cap [Figs. 1A-B]. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 12-13 is/are rejected under 35 U.S.C. 103 as being unpatentable over Whelehan in view of Taheri [US 6120524 A]. Re. claim 12 and 13, Whelehan discloses: the medical device of claim 1, but fails to teach the patch comprising one or more wires which bias the patch into a shape. However, Taheri teaches, in a medical device, a patch [16, Figs. 2-7] comprises one or more wires [wire loop 28”], wherein Claim 12: each of the one or more wires extend throughout a length of the patch [Fig. 4], and wherein the one or more wires bias the patch into a shape [Col 2 lines 32-40]. Claim 13: the one or more wires are biased It would have been obvious to one of ordinary skill in the art before the effective filing date of the invention to modify the apparatus of Whelehan to add a wire biased to a circular shape to bias the patch into a shape, as taught by Taheri, in order to allow the patch to be delivered in a folded, compact shape through a catheter and deployed into an unfolded, desired shape [Taheri Col. 2 lines 32-54]. Allowable Subject Matter Claims 16-20 are allowed. Claims 5-11 and 14 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: the closest prior art of record fails to teach or suggest the opposite edges including channels, the stationary portion of the end cap having through-hole(s) with the control elements and actuation elements extending through the through-holes or the patch having channels configured to receive a first and second strand of the actuation element. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ERIN MCGRATH whose telephone number is (571)270-0674. The examiner can normally be reached M-Th 9 am to 3 pm ET. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, JACKIE HO can be reached at (571) 272-4696. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ERIN MCGRATH/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Dec 15, 2023
Application Filed
Jun 12, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12661137
Umbrella Catheter Device
3y 11m to grant Granted Jun 23, 2026
Patent 12636016
ENDOSCOPE CLIP AND OPERATION METHOD FOR CLIP ARM
5y 0m to grant Granted May 26, 2026
Patent 12636034
MEDICAL DEVICE
3y 10m to grant Granted May 26, 2026
Patent 12636411
UHMWPE DIP-COATED TUBES
1y 8m to grant Granted May 26, 2026
Patent 12616536
ROBOTIC SURGICAL SYSTEM WITH FLOATING PATIENT MOUNT
4y 0m to grant Granted May 05, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
60%
Grant Probability
90%
With Interview (+29.8%)
3y 6m (~11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 437 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month